The screens were performed to measure circulating (serum/plasma) and/or cleared (urine) proteins in biofluids from AAV9-CK8-microdystrophin-treated mdx mice, GRMD dogs, and DMD participants. This evidence concerns the gene KRT8 and Duchenne muscular dystrophy.